Chlorine in PDB 6zqz: [1,2,4]Triazolo[1,5-A]Pyrimidine Phosphodiesterase 2 Inhibitors
Enzymatic activity of [1,2,4]Triazolo[1,5-A]Pyrimidine Phosphodiesterase 2 Inhibitors
All present enzymatic activity of [1,2,4]Triazolo[1,5-A]Pyrimidine Phosphodiesterase 2 Inhibitors:
3.1.4.17;
Protein crystallography data
The structure of [1,2,4]Triazolo[1,5-A]Pyrimidine Phosphodiesterase 2 Inhibitors, PDB code: 6zqz
was solved by
G.Tresadern,
P.M.Leonard,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
87.07 /
1.88
|
Space group
|
P 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
55.960,
73.460,
92.230,
109.16,
91.37,
91.26
|
R / Rfree (%)
|
19.6 /
24.4
|
Other elements in 6zqz:
The structure of [1,2,4]Triazolo[1,5-A]Pyrimidine Phosphodiesterase 2 Inhibitors also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the [1,2,4]Triazolo[1,5-A]Pyrimidine Phosphodiesterase 2 Inhibitors
(pdb code 6zqz). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
[1,2,4]Triazolo[1,5-A]Pyrimidine Phosphodiesterase 2 Inhibitors, PDB code: 6zqz:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 6zqz
Go back to
Chlorine Binding Sites List in 6zqz
Chlorine binding site 1 out
of 4 in the [1,2,4]Triazolo[1,5-A]Pyrimidine Phosphodiesterase 2 Inhibitors
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of [1,2,4]Triazolo[1,5-A]Pyrimidine Phosphodiesterase 2 Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl1003
b:22.3
occ:1.00
|
CL1
|
A:QOQ1003
|
0.0
|
22.3
|
1.0
|
C12
|
A:QOQ1003
|
1.8
|
17.8
|
1.0
|
N11
|
A:QOQ1003
|
2.7
|
16.6
|
1.0
|
C13
|
A:QOQ1003
|
2.8
|
17.2
|
1.0
|
OH
|
A:TYR827
|
3.1
|
14.9
|
1.0
|
C21
|
A:QOQ1003
|
3.6
|
16.1
|
1.0
|
O
|
A:HOH1193
|
3.7
|
19.6
|
1.0
|
N20
|
A:QOQ1003
|
3.7
|
16.0
|
1.0
|
SD
|
A:MET847
|
3.8
|
22.6
|
1.0
|
OE1
|
A:GLN859
|
3.9
|
19.0
|
1.0
|
C10
|
A:QOQ1003
|
4.0
|
17.1
|
1.0
|
CZ
|
A:TYR827
|
4.0
|
13.7
|
1.0
|
C8
|
A:QOQ1003
|
4.1
|
16.8
|
1.0
|
CE2
|
A:PHE830
|
4.1
|
15.1
|
1.0
|
CE
|
A:MET847
|
4.2
|
23.0
|
1.0
|
CE2
|
A:TYR827
|
4.3
|
13.8
|
1.0
|
CB
|
A:PHE862
|
4.4
|
18.1
|
1.0
|
CB
|
A:MET847
|
4.4
|
20.4
|
1.0
|
O
|
A:LEU858
|
4.4
|
16.8
|
1.0
|
C9
|
A:QOQ1003
|
4.5
|
16.4
|
1.0
|
CB
|
A:LEU858
|
4.7
|
18.4
|
1.0
|
CG
|
A:PHE862
|
4.7
|
18.6
|
1.0
|
CD1
|
A:PHE862
|
4.8
|
19.3
|
1.0
|
CG
|
A:MET847
|
4.8
|
20.6
|
1.0
|
CD2
|
A:PHE830
|
4.8
|
14.9
|
1.0
|
C
|
A:LEU858
|
4.9
|
17.6
|
1.0
|
N22
|
A:QOQ1003
|
4.9
|
15.9
|
1.0
|
CE1
|
A:TYR827
|
5.0
|
13.6
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 6zqz
Go back to
Chlorine Binding Sites List in 6zqz
Chlorine binding site 2 out
of 4 in the [1,2,4]Triazolo[1,5-A]Pyrimidine Phosphodiesterase 2 Inhibitors
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of [1,2,4]Triazolo[1,5-A]Pyrimidine Phosphodiesterase 2 Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl1003
b:26.3
occ:1.00
|
CL1
|
B:QOQ1003
|
0.0
|
26.3
|
1.0
|
C12
|
B:QOQ1003
|
1.8
|
20.9
|
1.0
|
N11
|
B:QOQ1003
|
2.7
|
19.5
|
1.0
|
C13
|
B:QOQ1003
|
2.7
|
19.9
|
1.0
|
OH
|
B:TYR827
|
3.1
|
20.1
|
1.0
|
C21
|
B:QOQ1003
|
3.6
|
21.5
|
1.0
|
N20
|
B:QOQ1003
|
3.7
|
22.0
|
1.0
|
SD
|
B:MET847
|
3.9
|
22.7
|
1.0
|
CZ
|
B:TYR827
|
3.9
|
17.9
|
1.0
|
O
|
B:HOH1203
|
3.9
|
28.1
|
1.0
|
C10
|
B:QOQ1003
|
4.0
|
19.4
|
1.0
|
C8
|
B:QOQ1003
|
4.1
|
19.4
|
1.0
|
CE2
|
B:PHE830
|
4.1
|
15.9
|
1.0
|
CE2
|
B:TYR827
|
4.1
|
18.8
|
1.0
|
OE1
|
B:GLN859
|
4.2
|
27.0
|
1.0
|
O
|
B:LEU858
|
4.3
|
21.1
|
1.0
|
CB
|
B:PHE862
|
4.3
|
21.3
|
1.0
|
C9
|
B:QOQ1003
|
4.5
|
19.5
|
1.0
|
CB
|
B:LEU858
|
4.5
|
21.1
|
1.0
|
C
|
B:LEU858
|
4.6
|
21.4
|
1.0
|
CG
|
B:PHE862
|
4.7
|
21.1
|
1.0
|
CD1
|
B:PHE862
|
4.7
|
21.5
|
1.0
|
CD2
|
B:PHE830
|
4.9
|
15.9
|
1.0
|
CE
|
B:MET847
|
4.9
|
23.9
|
1.0
|
N22
|
B:QOQ1003
|
4.9
|
22.4
|
1.0
|
CZ
|
B:PHE830
|
5.0
|
16.0
|
1.0
|
CB
|
B:MET847
|
5.0
|
22.5
|
1.0
|
CE1
|
B:TYR827
|
5.0
|
18.0
|
1.0
|
CG
|
B:MET847
|
5.0
|
22.2
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 6zqz
Go back to
Chlorine Binding Sites List in 6zqz
Chlorine binding site 3 out
of 4 in the [1,2,4]Triazolo[1,5-A]Pyrimidine Phosphodiesterase 2 Inhibitors
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of [1,2,4]Triazolo[1,5-A]Pyrimidine Phosphodiesterase 2 Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Cl1003
b:25.0
occ:1.00
|
CL1
|
C:QOQ1003
|
0.0
|
25.0
|
1.0
|
C12
|
C:QOQ1003
|
1.8
|
22.2
|
1.0
|
N11
|
C:QOQ1003
|
2.7
|
20.8
|
1.0
|
C13
|
C:QOQ1003
|
2.7
|
21.5
|
1.0
|
OH
|
C:TYR827
|
3.2
|
19.2
|
1.0
|
C21
|
C:QOQ1003
|
3.6
|
23.0
|
1.0
|
N20
|
C:QOQ1003
|
3.7
|
22.6
|
1.0
|
O
|
C:HOH1158
|
3.8
|
17.7
|
1.0
|
CE2
|
C:PHE830
|
3.9
|
19.0
|
1.0
|
CZ
|
C:TYR827
|
3.9
|
18.4
|
1.0
|
C10
|
C:QOQ1003
|
4.0
|
21.1
|
1.0
|
SD
|
C:MET847
|
4.0
|
27.9
|
1.0
|
OE1
|
C:GLN859
|
4.0
|
24.2
|
1.0
|
C8
|
C:QOQ1003
|
4.0
|
21.1
|
1.0
|
CE2
|
C:TYR827
|
4.2
|
18.6
|
1.0
|
O
|
C:LEU858
|
4.3
|
20.9
|
1.0
|
CB
|
C:PHE862
|
4.3
|
19.4
|
1.0
|
CE
|
C:MET847
|
4.5
|
26.8
|
1.0
|
C9
|
C:QOQ1003
|
4.5
|
20.7
|
1.0
|
CD1
|
C:PHE862
|
4.6
|
19.5
|
1.0
|
CG
|
C:PHE862
|
4.6
|
19.6
|
1.0
|
CB
|
C:LEU858
|
4.7
|
22.8
|
1.0
|
CD2
|
C:PHE830
|
4.7
|
19.0
|
1.0
|
C
|
C:LEU858
|
4.7
|
22.9
|
1.0
|
CZ
|
C:PHE830
|
4.8
|
18.7
|
1.0
|
CB
|
C:MET847
|
4.8
|
28.6
|
1.0
|
N22
|
C:QOQ1003
|
5.0
|
22.2
|
1.0
|
CE1
|
C:TYR827
|
5.0
|
17.9
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 6zqz
Go back to
Chlorine Binding Sites List in 6zqz
Chlorine binding site 4 out
of 4 in the [1,2,4]Triazolo[1,5-A]Pyrimidine Phosphodiesterase 2 Inhibitors
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of [1,2,4]Triazolo[1,5-A]Pyrimidine Phosphodiesterase 2 Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Cl1003
b:26.6
occ:1.00
|
CL1
|
D:QOQ1003
|
0.0
|
26.6
|
1.0
|
C12
|
D:QOQ1003
|
1.8
|
22.8
|
1.0
|
N11
|
D:QOQ1003
|
2.7
|
22.3
|
1.0
|
C13
|
D:QOQ1003
|
2.8
|
22.7
|
1.0
|
OH
|
D:TYR827
|
3.2
|
16.8
|
1.0
|
O
|
D:HOH1224
|
3.6
|
16.2
|
1.0
|
C21
|
D:QOQ1003
|
3.6
|
21.9
|
1.0
|
SD
|
D:MET847
|
3.8
|
22.0
|
1.0
|
N20
|
D:QOQ1003
|
3.9
|
21.5
|
1.0
|
OE1
|
D:GLN859
|
3.9
|
27.7
|
1.0
|
C10
|
D:QOQ1003
|
4.0
|
21.6
|
1.0
|
C8
|
D:QOQ1003
|
4.1
|
21.4
|
1.0
|
CZ
|
D:TYR827
|
4.1
|
16.4
|
1.0
|
CB
|
D:PHE862
|
4.2
|
19.7
|
1.0
|
O
|
D:LEU858
|
4.2
|
18.1
|
1.0
|
CE2
|
D:PHE830
|
4.3
|
17.0
|
1.0
|
CE
|
D:MET847
|
4.4
|
23.5
|
1.0
|
CE2
|
D:TYR827
|
4.5
|
16.8
|
1.0
|
CB
|
D:LEU858
|
4.5
|
19.9
|
1.0
|
CG
|
D:PHE862
|
4.5
|
19.8
|
1.0
|
C9
|
D:QOQ1003
|
4.5
|
21.5
|
1.0
|
C
|
D:LEU858
|
4.6
|
19.7
|
1.0
|
CD1
|
D:PHE862
|
4.6
|
19.9
|
1.0
|
CB
|
D:MET847
|
4.7
|
21.7
|
1.0
|
CG
|
D:MET847
|
4.8
|
21.9
|
1.0
|
N22
|
D:QOQ1003
|
4.9
|
21.7
|
1.0
|
|
Reference:
G.Tresadern,
I.Velter,
A.A.Trabanco,
F.Van Den Keybus,
G.J.Macdonald,
M.V.F.Somers,
G.Vanhoof,
P.M.Leonard,
M.B.A.C.Lamers,
Y.E.M.Van Roosbroeck,
P.J.J.A.Buijnsters.
[1,2,4]Triazolo[1,5- A ]Pyrimidine Phosphodiesterase 2A Inhibitors: Structure and Free-Energy Perturbation-Guided Exploration. J.Med.Chem. V. 63 12887 2020.
ISSN: ISSN 0022-2623
PubMed: 33105987
DOI: 10.1021/ACS.JMEDCHEM.0C01272
Page generated: Mon Jul 29 18:10:08 2024
|